Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

NCT06238245 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Graft-versus-host Disease
Hematological Malignancies

Interventions

DRUG: Cyclophosphamid

Sponsor

Beijing 302 Hospital